Biologic and clinical evaluation of high intermittent dose all trans retinoic acid (ATRA) in refractory multiple myeloma (MM) patients (PTS).

被引：0
|
作者：
Hussein, MA [1 ]
Bocock, K [1 ]
Bloom, T [1 ]
Finke, J [1 ]
Rybicki, L [1 ]
Scott, R [1 ]
Bukowski, RM [1 ]
机构：
[1] Cleveland Clin, Ctr Canc, Cleveland, OH 44106 USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
444
引用
收藏
页码：108A / 109A
页数：2
相关论文
共 50 条
  • [1] High dose all-trans retinoic acid (ATRA) in multiple myeloma (MM).
    Hussein, MA
    Zuccaro, K
    Bloom, T
    Finke, J
    Elson, P
    Bukowski, RM
    BLOOD, 1997, 90 (10) : 4133 - 4133
  • [2] High, intermittent dose of all-trans retinoic acid in combination with α-interferon for advanced multiple myeloma
    Juturi, J
    Bukowski, RA
    Bocock, K
    Bloom, T
    Finke, J
    Hussein, MA
    HAEMATOLOGICA, 2001, 86 (07) : 776 - 777
  • [3] Biologic and clinical evaluation of rituxan (RT) in the management of newly diagnosed multiple myeloma (MM) patients(pts).
    Hussein, MA
    Karam, MA
    McLain, DA
    Elson, P
    Hsi, E
    BLOOD, 1999, 94 (10) : 313A - 313A
  • [4] INTERMITTENT ALL-TRANS-RETINOIC ACID (ATRA) FOR THE TREATMENT OF MYELODYSPLASIA (MDS)
    KAHN, MJ
    STADTMAUER, EA
    EDELSTEIN, M
    SALHANEY, K
    LUGER, S
    SKALLA, K
    NOWELL, P
    BERGER, M
    BLOOD, 1994, 84 (10) : A632 - A632
  • [5] Dexamethasone, all trans retinoic acid and interferon alpha 2a in patients with refractory multiple myeloma
    Avilés, A
    Rosas, A
    Huerta-Guzmán, J
    Talavera, A
    Cleto, S
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1999, 14 (01) : 23 - 26
  • [6] Effects of all-trans retinoic acid (ATRA) on human myeloma cells
    Otsuki, T
    Sakaguchi, H
    Hatayama, T
    Wu, P
    Takata, A
    Hyodoh, F
    LEUKEMIA & LYMPHOMA, 2003, 44 (10) : 1651 - 1656
  • [7] BIOLOGICAL RESPONSE MODIFIERS (BRM)IN REFRACTORY MULTIPLE-MYELOMA (MM) - LACK OF CLINICAL EFFICACY OF RECOMBINANT HUMAN INTERLEUKIN-4 (RHIL-4) AND ALL-TRANS-RETINOIC ACID (ATRA)
    VESOLE, D
    KORNBLUTH, J
    JAGANNATH, S
    SZNOL, M
    MATTOX, S
    VAUGHT, L
    TRICOT, G
    BARLOGIE, B
    BLOOD, 1993, 82 (10) : A263 - A263
  • [8] All-trans retinoic acid for multiple myeloma.
    Weber, DM
    Bseiso, A
    Wood, A
    Gavino, M
    Alexanian, R
    BLOOD, 1997, 90 (10) : 1593 - 1593
  • [9] Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma
    Frerichs, Kristine A.
    Minnema, Monique C.
    Levin, Mark-David
    Broijl, Annemiek
    Bos, Gerard M. J.
    Kersten, Marie Jose
    Mutis, Tuna
    Verkleij, Christie P. M.
    Nijhof, Inger S.
    Maas-Bosman, Patricia W. C.
    Klein, Saskia K.
    Zweegman, Sonja
    Sonneveld, Pieter
    van de Donk, Niels W. C. J.
    BLOOD ADVANCES, 2021, 5 (23) : 5128 - 5139
  • [10] Neoplasias after high-dose melphalan for multiple myeloma (MM) patients (pts)
    da Costa, F. Leal
    Miranda, N.
    Coelho, J. L. Passos
    Guimaraes, A.
    Ferreira, I.
    Teixeira, G.
    Fernandez, E.
    Abecasis, M. M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S443 - S443
12345